BACKGROUND
Oral anticoagulation (OAC) remains the cornerstone of stroke prevention in atrial fibrillation (AF) but is limited by bleeding risk. Left atrial appendage occlusion (LAAO) devices offer an alternative; however, recent randomized trials have reported inconsistent efficacy compared with OAC.
METHODS
We condu...
Z. Bashir, M. Abdul Rehman, Mohammad Hamza et al.· Pacing and clinical electrop...· 0 citations
Background:
Oral anticoagulation (OAC) remains the cornerstone of stroke prevention in atrial fibrillation (AF), but its use is limited by bleeding risk. Left atrial appendage occlusion (LAAO) devices offer a nonpharmacological alternative; however, recent randomized trials have reported inconsistent efficacy compar...
Z. Bashir, M. Abdul Rehman, M. Yang et al.· Circulation· 0 citations
Background:
While antiphospholipid antibodies (aPL) are mechanistically linked to venous thromboembolism (VTE), the prevalence of aPL among patients with VTE remains incompletely characterized and estimates of their association with first and recurrent VTE vary across individual studies.
Methods:
We systematic...
S. Bukhari, Nathan W. Watson, S. Rashedi et al.· Circulation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.